DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 177 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2024. The put-call ratio across all filers is 5.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $92,807,000 | +10.6% | 5,900,000 | +13.5% | 1.23% | +7.5% |
Q4 2023 | $83,876,000 | +43.0% | 5,200,000 | +12.7% | 1.14% | +27.4% |
Q3 2023 | $58,664,640 | -8.6% | 4,612,000 | +1.1% | 0.90% | -3.2% |
Q2 2023 | $64,204,800 | +1.4% | 4,560,000 | +11.2% | 0.93% | +1.9% |
Q1 2023 | $63,345,000 | -25.3% | 4,100,000 | -20.7% | 0.91% | -38.3% |
Q4 2022 | $84,769,080 | -3.9% | 5,172,000 | +8.5% | 1.48% | -3.3% |
Q3 2022 | $88,208,000 | +24.2% | 4,768,000 | -11.7% | 1.53% | +23.5% |
Q2 2022 | $71,010,000 | +31.3% | 5,400,000 | -7.5% | 1.24% | +18.5% |
Q1 2022 | $54,100,000 | +61.4% | 5,836,000 | +70.1% | 1.05% | +90.9% |
Q4 2021 | $33,513,000 | +45.5% | 3,430,154 | +405.9% | 0.55% | +40.5% |
Q3 2021 | $23,038,000 | +33.3% | 678,000 | +43.6% | 0.39% | +26.2% |
Q2 2021 | $17,280,000 | – | 472,000 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $15,385,743 | 19.76% |
Redmile Group, LLC | 4,475,384 | $56,926,884 | 2.71% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,897,606 | $87,737,548 | 1.93% |
Parkman Healthcare Partners LLC | 597,403 | $7,598,966 | 1.39% |
Ghost Tree Capital, LLC | 325,000 | $4,134,000 | 1.36% |
BRAIDWELL LP | 3,336,221 | $42,436,731 | 1.34% |
AlphaCentric Advisors LLC | 132,000 | $1,679,040 | 0.95% |
ARMISTICE CAPITAL, LLC | 4,612,000 | $58,664,640 | 0.90% |
Sunesis Advisors, LLC | 96,299 | $1,224,923 | 0.87% |
EcoR1 Capital, LLC | 993,000 | $12,630,960 | 0.43% |